Invasive potential of gut mucosa‐derived fusobacterium nucleatum positively correlates with IBD status of the host

Background: Fusobacterium nucleatum is a heterogeneous oral pathogen that is also a common resident of the human gut mucosa. Given that some strains of F. nucleatum are known to be invasive and proinflammatory in the oral mucosa, we compared strains isolated from patients with inflammatory bowel disease (IBD) with strains isolated from healthy controls to determine 1) whether this species was more commonly associated with IBD patients; and 2) whether gut‐derived F. nucleatum strains from IBD patients showed an increased capacity for invasion. Methods: Biopsy material was obtained from 56 adult patients undergoing colonoscopy for colon cancer screening purposes or assessment of irritable bowel syndrome status (34 patients), or to assess for presence of gastrointestinal disease (i.e., IBD or indeterminate colitis, 22 patients). We enumerated Fusobacterium spp. strains isolated from human gut biopsy material in a blinded fashion, and then compared the virulence potential of a subset of F. nucleatum strains using an invasion assay in a Caco‐2 model system. Results: Fusobacterium spp. were isolated from 63.6% of patients with gastrointestinal disease compared to 26.5% of healthy controls (P = 0.01). In total, 69% of all Fusobacterium spp. recovered from patients were identified as F. nucleatum. F. nucleatum strains originating from inflamed biopsy tissue from IBD patients were significantly more invasive in a Caco‐2 cell invasion assay than strains that were isolated from healthy tissue from either IBD patients or control patients (P < 0.05 to 0.001). Conclusions: This study indicates that colonization of the intestinal mucosa by highly invasive strains of F. nucleatum may be a useful biomarker for gastrointestinal disease. (Inflamm Bowel Dis 2011;)

[1]  M. Weizenegger,et al.  Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum , 2009, Gut.

[2]  E. Nielsen,et al.  A phylogenetic group of Escherichia coli associated with active left-sided Inflammatory Bowel Disease , 2009, BMC Microbiology.

[3]  Michael A McGuckin,et al.  Intestinal barrier dysfunction in inflammatory bowel diseases. , 2009, Inflammatory bowel diseases.

[4]  E. Allen-Vercoe,et al.  Phenotypic and genotypic analyses of clinical Fusobacterium nucleatum and Fusobacterium periodonticum isolates from the human gut. , 2008, Anaerobe.

[5]  V. Uitto,et al.  Intracellular replication of fusobacteria requires new actin filament formation of epithelial cells   , 2008, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[6]  S. Macfarlane,et al.  Coaggregation between and among human intestinal and oral bacteria. , 2008, FEMS microbiology ecology.

[7]  R Balfour Sartor,et al.  Microbial influences in inflammatory bowel diseases. , 2008, Gastroenterology.

[8]  R. Knight,et al.  The Human Microbiome Project , 2007, Nature.

[9]  N. Pace,et al.  Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases , 2007, Proceedings of the National Academy of Sciences.

[10]  Shadi Sepehri,et al.  Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease , 2007, Inflammatory bowel diseases.

[11]  U. Gophna,et al.  Differences between Tissue-Associated Intestinal Microfloras of Patients with Crohn's Disease and Ulcerative Colitis , 2006, Journal of Clinical Microbiology.

[12]  W. Wade,et al.  Genotypic and phenotypic characterization of fusobacteria from Chinese and European patients with inflammatory periodontal diseases. , 2006, Systematic and applied microbiology.

[13]  C. Manichanh,et al.  Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach , 2005, Gut.

[14]  A. Edwards,et al.  Fusobacterium nucleatum Transports Noninvasive Streptococcus cristatus into Human Epithelial Cells , 2006, Infection and Immunity.

[15]  Mi-Sun Kang,et al.  Coaggregation ability of Weissella cibaria isolates with Fusobacterium nucleatum and their adhesiveness to epithelial cells. , 2005, FEMS microbiology letters.

[16]  C. G. Diniz,et al.  Enhanced pathogenicity of Fusobacterium nucleatum adapted to oxidative stress. , 2005, Microbial pathogenesis.

[17]  Yun Zhou,et al.  Identification and Characterization of a Novel Adhesin Unique to Oral Fusobacteria , 2005, Journal of bacteriology.

[18]  Molecular identification of an invasive gingival bacterial community. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  E. Weiss,et al.  Fluorescence based measurements of Fusobacterium nucleatum coaggregation and of fusobacterial attachment to mammalian cells. , 2005, FEMS microbiology letters.

[20]  Qiang Wu,et al.  Fusobacterium nucleatum Increases Collagenase 3 Production and Migration of Epithelial Cells , 2005, Infection and Immunity.

[21]  D. Cowan,et al.  Review and re-analysis of domain-specific 16S primers. , 2003, Journal of microbiological methods.

[22]  S. Ebisu,et al.  An immunohistological study of the localization of bacteria invading root pulpal walls of teeth with periapical lesions. , 2003, Journal of endodontics.

[23]  T. Ohkusa,et al.  Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis , 2003, Gut.

[24]  D. Citron.  Update on the taxonomy and clinical aspects of the genus fusobacterium. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  T. Ohkusa,et al.  Fusobacterium varium localized in the colonic mucosa of patients with ulcerative colitis stimulates species‐specific antibody , 2002, Journal of gastroenterology and hepatology.

[26]  C. Neut,et al.  Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease , 2002, American Journal of Gastroenterology.

[27]  P. Diaz,et al.  The response to oxidative stress of Fusobacterium nucleatum grown in continuous culture. , 2000, FEMS microbiology letters.

[28]  R. Genco,et al.  Interactions between Periodontal Bacteria and Human Oral Epithelial Cells: Fusobacterium nucleatum Adheres to and Invades Epithelial Cells , 2000, Infection and Immunity.

[29]  T. Thurnheer,et al.  Infinite Serovar and Ribotype Heterogeneity Among Oral Fusobacterium nucleatum Strains , 1999 .

[30]  B. Finlay,et al.  Enteropathogenic Escherichia coli inhibits phagocytosis. , 1999, Infection and immunity.

[31]  N. Barnich,et al.  Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. , 1998, Gastroenterology.

[32]  W E Moore,et al.  The bacteria of periodontal diseases. , 1994, Periodontology 2000.

[33]  E. Goldstein,et al.  A selective medium for Fusobacterium spp. , 1991, The Journal of applied bacteriology.

[34]  P. Bartold,et al.  Identification of components in Fusobacterium nucleatum chemostat-culture supernatants that are potent inhibitors of human gingival fibroblast proliferation. , 1991, Journal of periodontal research.

[35]  P. Lawson,et al.  Distribution and frequency of Fusobacterium nucleatum subspecies in the human oral cavity. , 1990, Oral microbiology and immunology.

[36]  T. Hofstad,et al.  Outer membrane proteins as major antigens of Fusobacterium nucleatum. , 1989, FEMS microbiology immunology.